Flunarizine hydrochloride is a calcium antagonist drug that acts by reducing or preventing migraine headaches. This drug is used to treat dizziness and vertigo.
Growth in the prevalence of migraine, increasing consumption of junk food, smoking and drinking, and hectic and stressful lifestyle that leads to migraines drive the flunarizine hydrochloride market growth.

The global Flunarizine Hydrochloride market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Flunarizine Hydrochloride volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Flunarizine Hydrochloride market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Flunarizine Hydrochloride Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Tablets
Capsules

Segment by Application
Hospital
Clinic
Clinical Institution
Academic Research
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Johnson and Johnson
Cipla Limited
Torrent Pharmaceuticals
Aa Pharma
Karnataka Antibiotics and Pharmaceuticals
Cadila Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
Fdc
Alkem Laboratories
Intas Pharmaceuticals